Efficacy of selenium supplementation for mild-to-moderate Graves’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial

BACKGROUND: The therapeutic effect of selenium has been demonstrated in mild Graves’ ophthalmopathy (GO) in a European region where selenium status is suboptimal. However, there is a lack of evidence to support selenium use in selenium-sufficient areas. The aim of this study is to evaluate the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Chae Won, Jung, Kyong Yeun, Jung, Eun Hye, Lee, Min Joung, Park, Young Joo, Lee, Jeong Kyu, Ahn, Hwa Young, Cho, Sun Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103450/
https://www.ncbi.nlm.nih.gov/pubmed/37060084
http://dx.doi.org/10.1186/s13063-023-07282-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103450/
https://www.ncbi.nlm.nih.gov/pubmed/37060084
http://dx.doi.org/10.1186/s13063-023-07282-4

Ejemplares similares